Cargando…

Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers

Default mode network (DMN) dysfunction (particularly within the anterior cingulate cortex (ACC) and medial prefrontal cortex (mPFC)) has been implicated in major depressive disorder (MDD); however, its contribution to treatment outcome has not been clearly established. Here we tested the role of DMN...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldstein-Piekarski, Andrea N., Staveland, Brooke R., Ball, Tali M., Yesavage, Jerome, Korgaonkar, Mayuresh S., Williams, Leanne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838245/
https://www.ncbi.nlm.nih.gov/pubmed/29507282
http://dx.doi.org/10.1038/s41398-018-0100-3
_version_ 1783304219538751488
author Goldstein-Piekarski, Andrea N.
Staveland, Brooke R.
Ball, Tali M.
Yesavage, Jerome
Korgaonkar, Mayuresh S.
Williams, Leanne M.
author_facet Goldstein-Piekarski, Andrea N.
Staveland, Brooke R.
Ball, Tali M.
Yesavage, Jerome
Korgaonkar, Mayuresh S.
Williams, Leanne M.
author_sort Goldstein-Piekarski, Andrea N.
collection PubMed
description Default mode network (DMN) dysfunction (particularly within the anterior cingulate cortex (ACC) and medial prefrontal cortex (mPFC)) has been implicated in major depressive disorder (MDD); however, its contribution to treatment outcome has not been clearly established. Here we tested the role of DMN functional connectivity as a general and differential biomarker for predicting treatment outcomes in a large, unmedicated adult sample with MDD. Seventy-five MDD outpatients completed fMRI scans before and 8 weeks after randomization to escitalopram, sertraline, or venlafaxine-XR. A whole-brain voxel-wise t-test identified profiles of pretreatment intrinsic functional connectivity that distinguished patients who were subsequently classified as remitters or non-remitters at follow-up. Connectivity was seeded in the PCC, an important node of the DMN. We further characterized differences between remitters, non-remitters, and 31 healthy controls and characterized changes pretreatment to posttreatment. Remitters were distinguished from non-remitters by relatively intact connectivity between the PCC and ACC/mPFC, not distinguishable from healthy controls, while non-remitters showed relative hypo-connectivity. In validation analyses, we demonstrate that PCC–ACC/mPFC connectivity predicts remission status with >80% cross-validated accuracy. In analyses testing whether intrinsic connectivity differentially relates to outcomes for a specific type of antidepressant, interaction models did not survive the corrected threshold. Our findings demonstrate that the overall capacity to remit on commonly used antidepressants may depend on intact organization of intrinsic functional connectivity between PCC and ACC/mPFC prior to treatment. The findings highlight the potential utility of functional scans for advancing a more precise approach to tailoring antidepressant treatment choices.
format Online
Article
Text
id pubmed-5838245
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-58382452018-03-06 Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers Goldstein-Piekarski, Andrea N. Staveland, Brooke R. Ball, Tali M. Yesavage, Jerome Korgaonkar, Mayuresh S. Williams, Leanne M. Transl Psychiatry Article Default mode network (DMN) dysfunction (particularly within the anterior cingulate cortex (ACC) and medial prefrontal cortex (mPFC)) has been implicated in major depressive disorder (MDD); however, its contribution to treatment outcome has not been clearly established. Here we tested the role of DMN functional connectivity as a general and differential biomarker for predicting treatment outcomes in a large, unmedicated adult sample with MDD. Seventy-five MDD outpatients completed fMRI scans before and 8 weeks after randomization to escitalopram, sertraline, or venlafaxine-XR. A whole-brain voxel-wise t-test identified profiles of pretreatment intrinsic functional connectivity that distinguished patients who were subsequently classified as remitters or non-remitters at follow-up. Connectivity was seeded in the PCC, an important node of the DMN. We further characterized differences between remitters, non-remitters, and 31 healthy controls and characterized changes pretreatment to posttreatment. Remitters were distinguished from non-remitters by relatively intact connectivity between the PCC and ACC/mPFC, not distinguishable from healthy controls, while non-remitters showed relative hypo-connectivity. In validation analyses, we demonstrate that PCC–ACC/mPFC connectivity predicts remission status with >80% cross-validated accuracy. In analyses testing whether intrinsic connectivity differentially relates to outcomes for a specific type of antidepressant, interaction models did not survive the corrected threshold. Our findings demonstrate that the overall capacity to remit on commonly used antidepressants may depend on intact organization of intrinsic functional connectivity between PCC and ACC/mPFC prior to treatment. The findings highlight the potential utility of functional scans for advancing a more precise approach to tailoring antidepressant treatment choices. Nature Publishing Group UK 2018-03-06 /pmc/articles/PMC5838245/ /pubmed/29507282 http://dx.doi.org/10.1038/s41398-018-0100-3 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Goldstein-Piekarski, Andrea N.
Staveland, Brooke R.
Ball, Tali M.
Yesavage, Jerome
Korgaonkar, Mayuresh S.
Williams, Leanne M.
Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers
title Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers
title_full Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers
title_fullStr Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers
title_full_unstemmed Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers
title_short Intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers
title_sort intrinsic functional connectivity predicts remission on antidepressants: a randomized controlled trial to identify clinically applicable imaging biomarkers
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838245/
https://www.ncbi.nlm.nih.gov/pubmed/29507282
http://dx.doi.org/10.1038/s41398-018-0100-3
work_keys_str_mv AT goldsteinpiekarskiandrean intrinsicfunctionalconnectivitypredictsremissiononantidepressantsarandomizedcontrolledtrialtoidentifyclinicallyapplicableimagingbiomarkers
AT stavelandbrooker intrinsicfunctionalconnectivitypredictsremissiononantidepressantsarandomizedcontrolledtrialtoidentifyclinicallyapplicableimagingbiomarkers
AT balltalim intrinsicfunctionalconnectivitypredictsremissiononantidepressantsarandomizedcontrolledtrialtoidentifyclinicallyapplicableimagingbiomarkers
AT yesavagejerome intrinsicfunctionalconnectivitypredictsremissiononantidepressantsarandomizedcontrolledtrialtoidentifyclinicallyapplicableimagingbiomarkers
AT korgaonkarmayureshs intrinsicfunctionalconnectivitypredictsremissiononantidepressantsarandomizedcontrolledtrialtoidentifyclinicallyapplicableimagingbiomarkers
AT williamsleannem intrinsicfunctionalconnectivitypredictsremissiononantidepressantsarandomizedcontrolledtrialtoidentifyclinicallyapplicableimagingbiomarkers